The First Thirty is an early-stage venture firm investing in AgriHealth: the deeptech and physical AI proving the link between how food is grown and how long, and how well, people live.
Decades of extractive farming have depleted essential nutrients from our soil.
Food producers struggle with unreliable supply chains while farmers face growing uncertainty due to soil degradation, energy prices and logistics disruptions.
Nutrient-depleted food contributes to trillions of annual healthcare spend on preventable conditions.
Rising consumer awareness outstrips capacity exposing the gap between what people want and what farms deliver.
We are at a digital inflection point in biology and artificial intelligence, unlocking unprecedented opportunities for AgriHealth investments. These technologies allow us to measure, optimise and deliver nutritional value with accuracy that was unthinkable just years ago.
By addressing health at its source, we are driving the transition from reactive symptom management to preventative health optimisation.
This represents a platform-level disruption across the food-health continuum. We invest in companies that fundamentally reshape how we grow, distribute and consume food for optimal human and planetary health.
Improved soil health leads to nutrient-dense food which creates measurable positive health outcomes. Regenerative practices provide significant environmental and biodiversity benefits.
Collaboration with nature and precision agriculture can dramatically minimize toxic farm inputs and reduce harmful health consequences. Food safety can be measured and delivered real-time to consumers.
We are building a portfolio of early stage companies that measure and optimise biological quality to increase nutrients and reduce toxins in order to deliver health outcomes from soil to plate.
Our portfolio forms the infrastructure connecting farm-level measurement to consumer verification collectively forming the foundations of a new AgriHealth category.
We are looking for innovations that:
Investing in early-stage innovators turning extraction into regeneration across agriculture, health, and technology.
